Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 16 | 15 | 2007 | 2014 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 16 | 15 | 2007 | 2014 | ||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
phenotype | 0.100 | None | 1.000 | 15 | 35 | 2008 | 2019 | ||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
phenotype | 0.100 | None | 1.000 | 15 | 35 | 2008 | 2013 | ||||||||
|
nectin cell adhesion molecule 2 | 0.575 | 0.769 | 0.97 |
|
disease | 0.440 | None | 1.000 | 14 | 20 | 2008 | 2019 | ||||||||
|
ZPR1 zinc finger | 0.674 | 0.462 | 8.9E-09 |
|
phenotype | 0.100 | None | 1.000 | 14 | 17 | 2008 | 2019 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 12 | 23 | 2007 | 2020 | |||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 12 | 29 | 2008 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 12 | 29 | 2008 | 2013 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
phenotype | 0.100 | None | 1.000 | 12 | 10 | 2007 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
phenotype | 0.100 | None | 1.000 | 12 | 18 | 2008 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
phenotype | 0.100 | None | 1.000 | 12 | 18 | 2008 | 2013 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.500 | None | 1.000 | 11 | 21 | 2005 | 2019 | |||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
phenotype | 0.100 | None | 1.000 | 11 | 53 | 2008 | 2019 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
phenotype | 0.100 | None | 1.000 | 11 | 53 | 2008 | 2014 | ||||||||
|
zinc finger and BTB domain containing 38 | 0.663 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 11 | 9 | 2008 | 2013 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
phenotype | 0.100 | None | 1.000 | 11 | 27 | 2007 | 2019 | ||||||||
|
cancer susceptibility 16 | 0.780 | 0.308 |
|
disease | 0.200 | None | 1.000 | 11 | 4 | 2007 | 2020 | |||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
phenotype | 0.100 | None | 1.000 | 10 | 27 | 2008 | 2013 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 10 | 44 | 2007 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 10 | 20 | 2008 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.100 | None | 1.000 | 10 | 7 | 2007 | 2013 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.140 | None | 1.000 | 9 | 5 | 2007 | 2019 | |||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 9 | 12 | 2010 | 2018 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 9 | 9 | 2008 | 2019 |